Achieving success where other molecules fail
Peptides designed with the IPROTech platform provide an alternative source of potent and selective Protein-Protein Interaction (PPI) modulators. These molecules occupy the chemical gap between small molecules and biologics. Moreover, IPROTech compounds suitably cover the chemical space required to modulate PPIs, thus making these molecules an appealing approach for the pharmaceutical industry.
What sets Iproteos apart is its focused expertise on the modulation of PPIs and PLIs (Protein-Ligand Interactions) by means of designed compounds that present high permeability across biological barriers, such as the gastrointestinal tract (GIT) and the blood-brain barrier (BBB). In addition, IPROTech compounds offer other advantages such as high stability and low toxicity and immunogenicity in comparison with other therapeutic approaches.